Effect of Selectively Introducing Arginine and D-Amino Acids on the Antimicrobial Activity and Salt Sensitivity in Analogs of Human Beta-Defensins

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Olli, Sudar ^a   Rangaraj, Nandini ^a   Nagaraj, Ramakrishnan ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ARGININE; BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 3; CALCIUM ION; CARBOXYFLUORESCEIN; DEXTRO AMINO ACID; DEXTRO ARGININE; HC 1 PEPTIDE; HC 3 PEPTIDE; ISOLEUCINE; MAGNESIUM ION; PHD 1 PEPTIDE; PHD 3 PEPTIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CANDIDA ALBICANS; CARBOXY TERMINAL SEQUENCE; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENCY; DRUG SYNTHESIS; ENANTIOMER; ESCHERICHIA COLI; IMAGE ANALYSIS; MOLECULAR IMAGING; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESIDUE ANALYSIS; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARGININE; BACTERIA; BETA-DEFENSINS; CANDIDA ALBICANS; CATIONS, DIVALENT; HUMANS; MOLECULAR SEQUENCE DATA; SODIUM CHLORIDE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84884696038     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077031     Document Type: Article

References (55)

1. Ganz T, (2005) Defensins and other antimicrobial peptides: a historical perspective and an update. Comb Chem High Throughput Screen 8: 209-217. doi:10.2174/1386207053764594. PubMed: 15892623.
2. Lehrer RI, (2004) Primate defensins. Nat Rev Microbiol 2: 727-738. doi:10.1038/nrmicro976. PubMed: 15372083.
3. Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J, (2006) Human beta-defensins. Cell Mol Life Sci 63: 1294-1313. doi:10.1007/s00018-005-5540-2. PubMed: 16710608.
4. Wiesner J, Vilcinskas A, (2010) Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1: 440-464. doi:10.4161/viru.1.5.12983. PubMed: 21178486.
5. Niyonsaba F, Nagaoka I, Ogawa H, (2006) Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit Rev Immunol 26: 545-576. doi:10.1615/CritRevImmunol.v26.i6.60. PubMed: 17341194.
6. Selsted ME, Ouellette AJ, (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6: 551-557. doi:10.1038/ni1206. PubMed: 15908936.
7. Huttner KM, Bevins CL, (1999) Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 45: 785-794. doi:10.1203/00006450-199906000-00001. PubMed: 10367766.
8. Fulton C, Anderson GM, Zasloff M, Bull R, Quinn AG, (1997) Expression of natural peptide antibiotics in human skin. Lancet 350: 1750-1751. doi:10.1016/S0140-6736(05)63574-X. PubMed: 9413472.
9. Harder J, Bartels J, Christophers E, Schröder JM, (1997) A peptide antibiotic from human skin. Nature 387: 861. doi:10.1038/43088. PubMed: 9202117.
10. Harder J, Bartels J, Christophers E, Schroder JM, (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276: 5707-5713. doi:10.1074/jbc.M008557200. PubMed: 11085990.
11. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, et al. (2002) Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118: 275-281. doi:10.1046/j.0022-202x.2001.01651.x. PubMed: 11841544.
12. Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC, (2005) Human defensins. J Mol Med (Berl) 83: 587-595. doi:10.1007/s00109-005-0657-1.
13. Zhao C, Wang I, Lehrer RI, (1996) Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 396: 319-322. doi:10.1016/0014-5793(96)01123-4. PubMed: 8915011.
14. García JR, Krause A, Schulz S, Rodríguez-Jiménez FJ, Klüver E, et al. (2001) Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 15: 1819-1821. PubMed: 11481241.
15. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, et al. (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88: 553-560. doi:10.1016/S0092-8674(00)81895-4. PubMed: 9038346.
16. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, et al. (1998) Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101: 1633-1642. doi:10.1172/JCI1861. PubMed: 9541493.
17. Bals R, Wang X, Wu Z, Freeman T, Bafna V, et al. (1998) Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102: 874-880. doi:10.1172/JCI2410. PubMed: 9727055.
18. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, et al. (1998) Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A 95: 14961-14966. doi:10.1073/pnas.95.25.14961. PubMed: 9843998.
19. Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J, (2003) Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother 47: 2804-2809. doi:10.1128/AAC.47.9.2804-2809.2003. PubMed: 12936977.
20. Klüver E, Adermann K, Schulz A, (2006) Synthesis and structure-activity relationship of beta-defensins, multi-functional peptides of the immune system. J Pept Sci 12: 243-257. doi:10.1002/psc.749. PubMed: 16491514.
21. Klüver E, Schulz-Maronde S, Scheid S, Meyer B, Forssmann WG, et al. (2005) Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 44: 9804-9816. doi:10.1021/bi050272k. PubMed: 16008365.
22. Krishnakumari V, Sharadadevi A, Singh S, Nagaraj R, (2003) Single disulfide and linear analogues corresponding to the carboxy-terminal segment of bovine beta-defensin-2: effects of introducing the beta-hairpin nucleating sequence d-pro-gly on antibacterial activity and Biophysical properties. Biochemistry 42: 9307-9315. doi:10.1021/bi034403y. PubMed: 12899617.
23. Krishnakumari V, Singh S, Nagaraj R, (2006) Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3. Peptides 27: 2607-2613. doi:10.1016/j.peptides.2006.06.004. PubMed: 16860904.
24. Mandal M, Jagannadham MV, Nagaraj R, (2002) Antibacterial activities and conformations of bovine beta-defensin BNBD-12 and analogs:structural and disulfide bridge requirements for activity. Peptides 23: 413-418. doi:10.1016/S0196-9781(01)00628-3. PubMed: 11835989.
25. Mandal M, Nagaraj R, (2002) Antibacterial activities and conformations of synthetic alpha-defensin HNP-1 and analogs with one, two and three disulfide bridges. J Pept Res 59: 95-104. doi:10.1034/j.1399-3011.2002.01945.x. PubMed: 11985703.
26. Pazgier M, Li X, Lu W, Lubkowski J, (2007) Human defensins: synthesis and structural properties. Curr Pharm Des 13: 3096-3118. doi:10.2174/138161207782110381. PubMed: 17979752.
27. Wu Z, Hoover DM, Yang D, Boulègue C, Santamaria F, et al. (2003) Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A 100: 8880-8885. doi:10.1073/pnas.1533186100. PubMed: 12840147.
28. Schroeder BO, Wu Z, Nuding S, Groscurth S, Marcinowski M, et al. (2011) Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 469: 419-423. doi:10.1038/nature09674. PubMed: 21248850.
29. Krishnakumari V, Rangaraj N, Nagaraj R, (2009) Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. Antimicrob Agents Chemother 53: 256-260. doi:10.1128/AAC.00470-08. PubMed: 18809937.
30. Wei G, de Leeuw E, Pazgier M, Yuan W, Zou G, et al. (2009) Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem 284: 29180-29192. doi:10.1074/jbc.M109.018085. PubMed: 19640840.
31. Xie C, Prahl A, Ericksen B, Wu Z, Zeng P, et al. (2005) Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. J Biol Chem 280: 32921-32929. doi:10.1074/jbc.M503084200. PubMed: 15894545.
32. Llenado RA, Weeks CS, Cocco MJ, Ouellette AJ, (2009) Electropositive charge in alpha-defensin bactericidal activity: functional effects of Lys-for-Arg substitutions vary with the peptide primary structure. Infect Immun 77: 5035-5043. doi:10.1128/IAI.00695-09. PubMed: 19737896.
33. Tanabe H, Qu X, Weeks CS, Cummings JE, Kolusheva S, et al. (2004) Structure-activity determinants in paneth cell alpha-defensins: loss-of-function in mouse cryptdin-4 by charge-reversal at arginine residue positions. J Biol Chem 279: 11976-11983. doi:10.1074/jbc.M310251200. PubMed: 14702345.
34. Zou G, de Leeuw E, Li C, Pazgier M, Zeng P, et al. (2007) Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs. J Biol Chem 282: 19653-19665. doi:10.1074/jbc.M611003200. PubMed: 17452329.
35. Tam JP, Wu CR, Liu W, Zhang JW, (1991) Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications. J Am Chem Soc 113: 6657-6662. doi:10.1021/ja00017a044.
36. Weber PJ, Bader JE, Folkers G, Beck-Sickinger AG, (1998) A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. Bioorg Med Chem Lett 8: 597-600. doi:10.1016/S0960-894X(98)00084-5. PubMed: 9871567.
37. Varkey J, Nagaraj R, (2005) Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines. Antimicrob Agents Chemother 49: 4561-4566. doi:10.1128/AAC.49.11.4561-4566.2005. PubMed: 16251296.
38. Tomita T, Hitomi S, Nagase T, Matsui H, Matsuse T, et al. (2000) Effect of ions on antibacterial activity of human beta defensin 2. Microbiol Immunol 44: 749-754. PubMed: 11092238.
39. Zucht HD, Grabowsky J, Schrader M, Liepke C, Jürgens M, et al. (1998) Human beta-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication. Eur J Med Res 3: 315-323. PubMed: 9682027.
40. Yu Q, Lehrer RI, Tam JP, (2000) Engineered salt-insensitive alpha-defensins with end-to-end circularized structures. J Biol Chem 275: 3943-3949. doi:10.1074/jbc.275.6.3943. PubMed: 10660548.
41. Scudiero O, Galdiero S, Cantisani M, Di Noto R, Vitiello M, et al. (2010) Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob Agents Chemother 54: 2312-2322. doi:10.1128/AAC.01550-09. PubMed: 20308372.
42. Sitaram N, Nagaraj R, (1999) Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim Biophys Acta 1462: 29-54. doi:10.1016/S0005-2736(99)00199-6. PubMed: 10590301.
43. Bai Y, Liu S, Jiang P, Zhou L, Li J, et al. (2009) Structure-dependent charge density as a determinant of antimicrobial activity of peptide analogues of defensin. Biochemistry 48: 7229-7239. doi:10.1021/bi900670d. PubMed: 19580334.
44. Jung S, Mysliwy J, Spudy B, Lorenzen I, Reiss K, et al. (2011) Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules. Antimicrob Agents Chemother 55: 954-960. doi:10.1128/AAC.00872-10. PubMed: 21189349.
45. Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, et al. (2002) The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem 277: 8279-8289. doi:10.1074/jbc.M108830200. PubMed: 11741980.
46. Seo ES, Blaum BS, Vargues T, De Cecco M, Deakin JA, et al. (2010) Interaction of human beta-defensin 2 (HBD2) with glycosaminoglycans. Biochemistry 49: 10486-10495. doi:10.1021/bi1011749. PubMed: 21062008.
47. Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, et al. (2000) The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem 275: 32911-32918. doi:10.1074/jbc.M006098200. PubMed: 10906336.
48. Chandrababu KB, Ho B, Yang D, (2009) Structure, dynamics, and activity of an all-cysteine mutated human beta defensin-3 peptide analogue. Biochemistry 48: 6052-6061. doi:10.1021/bi900154f. PubMed: 19480463.
49. Sass V, Schneider T, Wilmes M, Körner C, Tossi A, et al. (2010) Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun 78: 2793-2800. doi:10.1128/IAI.00688-09. PubMed: 20385753.
50. Hancock RE, Rozek A, (2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 206: 143-149. doi:10.1111/j.1574-6968.2002.tb11000.x. PubMed: 11814654.
51. Wu M, Maier E, Benz R, Hancock RE, (1999) Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38: 7235-7242. doi:10.1021/bi9826299. PubMed: 10353835.
52. Brissette CA, Lukehart SA, (2002) Treponema denticola is resistant to human beta-defensins. Infect Immun 70: 3982-3984. doi:10.1128/IAI.70.7.3982-3984.2002. PubMed: 12065549.
53. Starner TD, Swords WE, Apicella MA, McCray PB Jr, (2002) Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation. Infect Immun 70: 5287-5289. doi:10.1128/IAI.70.9.5287-5289.2002. PubMed: 12183584.
54. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, et al. (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274: 8405-8410. doi:10.1074/jbc.274.13.8405. PubMed: 10085071.
55. de Leeuw E, Li C, Zeng P, Diepeveen-de Buin M, Lu WY, et al. (2010) Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Lett 584: 1543-1548. doi:10.1016/j.febslet.2010.03.004. PubMed: 20214904.